FDA 483 - Manisha H Shah, M.D. - February 07, 2020

Dr. Manisha H Shah, a clinical investigator in Columbus, OH, received an FDA Form 483 citing a significant deviation from an investigational plan. The inspection revealed that required study assessments and questionnaires were not performed for multiple subjects across various cycles of a clinical trial. This indicates a failure to adhere to the established study protocol.